SCHEMBL21887768

SCHEMBL21887768

COc1cc2c(c(C)c1Br)CCC2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 2/20 0.46
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TSHR P16473 2/20 0.37
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
USP2 O75604 1/20 0.35
S100A4 P26447 1/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35
TUBB3 Q13509 1/20 0.35
TUBB2A Q13885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7998453 0.84 KDM4E (0.54) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL7123504 0.79 ALDH1A1 (0.33) KDM4EALDH1A1HPGDTSHRPDE3B
SCHEMBL11708730 0.75 BRD4 (0.46) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL9527144 0.74 KDM4E (0.50) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL388362 0.74 ALDH1A1 (0.69) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL6113045 0.74 KDM4E (0.64) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL4036037 0.74 ALDH1A1 (0.50) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL11115887 0.72 KDM4E (0.49) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL3987174 0.72 KDM4E (0.67) KDM4EALDH1A1HPGDGLAGAA
SCHEMBL3958125 0.72 KDM4E (0.60) KDM4EALDH1A1HPGDGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3680237-A1 PROCESS FOR PREPARING SUBSTITUTED 2,3-DIHYDRO-1H-INDEN-1-ONE RETINOIC ACID-RELATED ORPHAN NUCLEAR RECEPTOR ANTAGONISTS FOR TREATING MULTIPLE SCLEROSIS Arrien Pharmaceuticals LLC (US) 2020-07-15 EP disclosed
EP-3044223-B1 2,3-DIHYDRO-1H-INDEN-1-ONE DERIVATIVES AS RETINOIC ACID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA) ANTAGONISTS FOR TREATING MULTIPLE SCLEROSIS ARRIEN PHARMACEUTICALS LLC (US) 2020-04-01 EP disclosed